Who We Are
We are trailblazers. Everyday we work to create a new beginning for patients suffering from osteoarthritis.
Anton Clifford, Ph.D
Founder & CEO
Anton had the vision to identify the clinical need and invent the solution of the implantable shock absorber. His confidence to co-found Moximed after a successful rise through small company acquisition (MedNova) and parent company (Abbott) integration, combined with his resilience and sound judgment, serve as guideposts to a growing and ascending Moximed.
CHIEF FINANCIAL & STRATEGY OFFICER
James has extensive financial, strategic, and operational experience in med tech, including advising or leading >$2B in life sciences M&A activity over the course of his career. Most recently, James was a founding team member and Chief Business Officer at Palette Life Sciences where he helped drive a successful acquisition by Teleflex. With his track record of successfully scaling growth-stage companies, James will be instrumental to realizing the full potential of Moximed’s market opportunity.
VP Corporate Operations
Christine’s unique ability to lead multiple, diverse functions, helped drive the success of high growth medical technology companies (Kyphon, St. Francis Medical). Her passion for recognizing and recruiting talented team members who contribute to a thriving and entrepreneurial culture is instrumental to Moximed’s growth.
VP Marketing and Business Development
Keith’s delivered consistent results for medical device stalwarts (Boston Scientific, Guidant) across multiple clinical specialties and functional roles. His nuanced understanding of Moximed’s product and market positioning, combined with an ability to develop and implement highly effective strategies and build enduring customer relationships are essential to Moximed’s success.
Regulatory Counsel & VP Quality Affairs
Nancy’s track record for attaining regulatory product approvals and navigating complicated regulatory pathways is second to none. Her success is based on her professionalism and original, strategic thinking to overcome difficult challenges. While she established her credibility in the Fortune 500 (Becton Dickinson), Nancy thrives as a leader in the world of emerging companies with innovative technologies (NeoTract, Broncus, Avails) and is a pillar of Moximed’s success.
SVP Operations and Product Development
Wendy is a proven operations leader with a talent for building and scaling manufacturing for breakthrough medical devices. She brings a strategic approach and determined attitude to Moximed after previously heading operations for startups as well as blue-chip medical device companies (NeoTract, Boston Scientific, Guidant).
VP Clinical Affairs
Rose is a clinical research leader, bringing over 15 years of clinical expertise in Class II and III devices, while working for startups and Fortune 500 companies (J&J). Rose gravitates toward novel technologies, especially those that prioritize quality of life. Her leadership and drive to generate high-quality clinical evidence resulted in numerous regulatory approvals, publications, and favorable payer policies while at NeoTract (acquired by Teleflex) and more recently FDA market authorization of the MISHA Knee System while at Moximed.
Joshua Makower, M.D.
Anton Clifford, Ph.D.
Founder & CEO
Shahzad Malik, M.D.
David van Meter